Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
Candida Cytochrome P450 51 (Candi ERG11) |
Target Info
|
Inhibitor |
[3] |
| References |
Top |
| REF 1 |
FDA Approved Drug Products from FDA Official Website. 2022. Application Number: 215888.
|
| REF 2 |
ClinicalTrials.gov (NCT02267356) A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Onychomycosis of the Toenail. U.S. National Institutes of Health.
|
| REF 3 |
Efficacy of the clinical agent VT-1161 against fluconazole-sensitive and -resistant Candida albicans in a murine model of vaginal candidiasis. Antimicrob Agents Chemother. 2015 Sep;59(9):5567-73.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
